PO55 | Evaluation of safety and efficacy of emicizumab prophylaxis in pediatric patients with hemophilia A – a single centre experience
Background and Aims: Hemophilia A (HA) is an hereditary X-linked bleeding disorder secondary to deficiency of the clotting factor VIII (FVIII), that, if not properly treated, is associated with debilitating joint damage due to recurrent hemarthroses as well as life-threatening bleeds including intr...
Guardat en:
| Format: | Artigo |
|---|---|
| Idioma: | Inglês |
| Publicat: |
PAGEPress Publications
2025-10-01
|
| Col·lecció: | Bleeding, Thrombosis and Vascular Biology |
| Matèries: | |
| Accés en línia: | https://www.btvb.org/btvb/article/view/324 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|